Structures by: Nieger M.
Total: 390
C57H77CrN5O3P2,C55H74CrN4O3P2
C57H77CrN5O3P2,C55H74CrN4O3P2
Chemical Science (2020)
a=25.6854(10)Å b=20.8290(9)Å c=40.6993(18)Å
α=90° β=90° γ=90°
C55H73CrN4O3P2,C32H12BF24
C55H73CrN4O3P2,C32H12BF24
Chemical Science (2020)
a=12.5935(3)Å b=16.7577(4)Å c=21.3290(5)Å
α=95.414(1)° β=99.551(1)° γ=92.236(1)°
1,1,1,3,3,3-Hexafluoro-2-propanyloxy-(2,4,6-tri-tert-butylphenylimino)phosphine
C21H30F6NOP
Acta Chemica Scandinavica (1997) 51, 337-339
a=6.007(1)Å b=14.899(1)Å c=13.269(1)Å
α=90.° β=92.21(1)° γ=90.°
(Z)-1-(1-(mesitylimino)-2,2-dimethylpropyl)pyridin-1-ium triflate
C19H25N2,CF3O3S
Organic letters (2015) 17, 6 1461-1464
a=8.128(1)Å b=15.344(3)Å c=16.979(2)Å
α=90.00° β=102.44(1)° γ=90.00°
(Z)-4-(dimethylamino)-1-(1-(mesitylamino)-2,2-dimethylpropyl)pyridin-1-ium trifluoromethanesulfonate
C21H30N3,CF3O3S
Organic letters (2015) 17, 6 1461-1464
a=15.441(2)Å b=10.924(1)Å c=27.769(6)Å
α=90.00° β=90.90(2)° γ=90.00°
4-(dimethylamino)-1-((isopropylimino)(phenyl)methyl)pyridin- 1-ium trifluoromethanesulfonate
C17H22N3,CF3O3S
Organic letters (2015) 17, 6 1461-1464
a=8.4815(2)Å b=11.0740(3)Å c=21.3223(6)Å
α=90° β=93.426(1)° γ=90°
(Z)-N-(1-(1H-benzo[d]imidazol-1-yl)-2,2-dimethylpropylidene)aniline
C21H25N3
Organic letters (2015) 17, 6 1461-1464
a=8.610(1)Å b=9.179(1)Å c=11.835(1)Å
α=93.38(1)° β=95.73(1)° γ=105.20(1)°
(Z)-N-mesityl-N'-phenylpivalimidamide
C20H26N2
Organic letters (2015) 17, 6 1461-1464
a=8.693(1)Å b=17.464(2)Å c=11.525(1)Å
α=90° β=103.69(1)° γ=90°
(Z)-N'-mesitylpivalimidamide
C14H22N2
Organic letters (2015) 17, 6 1461-1464
a=26.3163(12)Å b=26.3163(12)Å c=10.4030(5)Å
α=90° β=90° γ=120°
2(C15H12O2),C8Cl2N2O2
2(C15H12O2),C8Cl2N2O2
Organic Chemistry Frontiers (2016) 3, 12 1738
a=14.2296(4)Å b=6.2823(2)Å c=33.8457(10)Å
α=90° β=90.3580(10)° γ=90°
(2S,3aR,7S,7aS)-Di-tert.butyl-7-hydroxy-4-oxo-2,3,3a,4-tetrahydro-1-H- indo-1,2(7H,7aH)-dicarboxylat
C18H27NO6
Organic letters (2009) 11, 20 4740-4742
a=9.355(1)Å b=11.918(1)Å c=17.310(2)Å
α=90.00° β=90.00° γ=90.00°
Benzyl[(1S)-1-(5-Amino-1,3,4-oxadiazol-2-yl)-2-phenylethyl]carbamate
C18H18N4O3
Crystals (2012) 2, 3 1201-1209
a=9.8152(2)Å b=9.6305(2)Å c=9.8465(2)Å
α=90.00° β=116.785(1)° γ=90.00°
Altechromone A
C11H10O3
Journal of natural products (2010) 73, 12 2064-2066
a=6.9503(2)Å b=16.4718(4)Å c=8.2909(2)Å
α=90.00° β=102.266(1)° γ=90.00°
7,7-diethyl-8-methyl-7,8-dihydroimidazo[2',1':3,4][1,4,2]-diazaborinino[1,6,5-gh]purin-11-ium-7-uide
C13H17BN6
Organic & biomolecular chemistry (2018) 16, 36 6801-6808
a=7.2834(4)Å b=7.5733(4)Å c=12.2004(7)Å
α=92.486(2)° β=94.926(2)° γ=96.678(2)°
7-Carboxy-2,4-dimethyl-5H-benzo[b][1,4]diazepin-ium picrate
(C12H13N2O2)(C6H2N3O7)MeOH
Organic & biomolecular chemistry (2003) 1, 23 4342-4350
a=8.8117(2)Å b=11.0726(2)Å c=11.2477(3)Å
α=79.339(1)° β=73.059(1)° γ=86.946(1)°
N-benzyl-4-methyl-N-(1-phenyl-1H-pyrazol-4-yl)benzenesulfonamide
C23H21N3O2S
Organic & biomolecular chemistry (2017) 15, 7 1575-1579
a=16.8632(5)Å b=5.6827(2)Å c=20.8486(6)Å
α=90° β=100.486(1)° γ=90°
N-benzyl-4-methyl-N-(1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)benzenesulfonamide
C24H20F3N3O2S
Organic & biomolecular chemistry (2017) 15, 7 1575-1579
a=5.9736(3)Å b=9.6554(5)Å c=19.0149(9)Å
α=83.760(2)° β=86.840(2)° γ=77.757(2)°
1-(4-Pyrrolidino)-(2,3,5,6-tetrachloropyridin-4-yl)- pyridinium tetrafluoroborate
C14H12Cl4N3BF4
Organic & biomolecular chemistry (2005) 3, 20 3788-3793
a=7.7703(1)Å b=20.6759(3)Å c=11.1315(2)Å
α=90.00° β=95.594(1)° γ=90.00°
Diethyl-1-(2-(5-(alloyoxy)-2,4-dimethoxyphenyl)-1-oxopropan-2- yl)hydrazine-1,2-dicarboxylate
C20H28N2O8
Organic & Biomolecular Chemistry (2009) 7, 24 5059-5062
a=8.681(1)Å b=9.784(1)Å c=24.875(3)Å
α=90.00° β=90.00° γ=90.00°
1,3,5,7-Tetrakis(4-(1-phenyl-1,2,3-triazol-4- yl)phenyl)adamantane
C70H56Cl12N12
Organic & Biomolecular Chemistry (2009) 7, 22 4734-4743
a=21.970(3)Å b=21.970(3)Å c=6.972(1)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(4-azidophenyl)methane
C25H16N12
Organic & Biomolecular Chemistry (2009) 7, 22 4734-4743
a=18.728(1)Å b=7.137(1)Å c=18.265(1)Å
α=90.00° β=111.37(1)° γ=90.00°
1-(2,6-Dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl)-4-morpholin-4- yl-pyridinium chloride
[C13H15N4O3][Cl](H2O)
Organic & biomolecular chemistry (2006) 4, 16 3056-3066
a=6.9530(1)Å b=7.9824(2)Å c=26.3031(6)Å
α=90.00° β=92.122(1)° γ=90.00°
Adeninediium dichloride
C5H7N5Cl2
Organic & biomolecular chemistry (2006) 4, 16 3056-3066
a=13.4485(12)Å b=6.4673(6)Å c=9.3711(6)Å
α=90.00° β=90.00° γ=90.00°
Rac-(2S,4S,6S)-2-methyl-2,3,4,6-tetrahydro-1H-2,6- methanobenzo(c)-(1,5)oxazocin-4-ol
C12H15NO2
Organic & biomolecular chemistry (2011) 9, 9 3136-3138
a=10.838(1)Å b=7.683(1)Å c=12.432(1)Å
α=90.00° β=97.66(1)° γ=90.00°
Rac-(2S,4S,6S)-2,10-dimethyl-2,3,4,6-tetrahydro-1H-2,6-methanobenzo[c]- [1,5]oxazocin-4-ol
C13H17NO2
Organic & biomolecular chemistry (2011) 9, 9 3136-3138
a=7.5344(6)Å b=22.2980(13)Å c=7.2117(7)Å
α=90.00° β=114.172(7)° γ=90.00°
10,10-diethyl-2-(2-hydroxyethyl)-6,8-dioxo-6,7,8,10-tetrahydro-1H-imidazo- [2',1:3,4][1,4,2]diazaborolo[1,5-c]pyrimidin-4-iunm-10-uide
C13H19BN4O3
Organic & biomolecular chemistry (2014) 12, 17 2737-2744
a=8.6058(4)Å b=7.5126(3)Å c=22.4696(8)Å
α=90° β=97.873(2)° γ=90°
1-benzyl-10,10-diethyl-6,8-dioxo-6,7,8,10-tetrahydro-1H-imidazo [2',1:3,4][1,4,2]diazaborolo[1,5-c]pyrimidin-4-ium-10-uide
C18H21BN4O2
Organic & biomolecular chemistry (2014) 12, 17 2737-2744
a=35.612(3)Å b=8.829(1)Å c=11.287(1)Å
α=90° β=90° γ=90°
Ethyl-4,6-di(1H-indol-3-yl)-1-phenylpiperidin-2-carboxylate
C30H29N3O2
Organic & biomolecular chemistry (2014) 12, 20 3265-3270
a=7.9687(8)Å b=9.4665(9)Å c=9.6211(9)Å
α=62.398(9)° β=77.124(8)° γ=81.985(8)°
Hexadecahydropyrazino[1,2-a:4,5-a']diindole-6,13-dione
C18H26N2O2
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=6.430(1)Å b=11.207(2)Å c=21.269(3)Å
α=90.00° β=90.00° γ=90.00°
Dodecahydro-6a,13a-epidithiopyrazino[1,2-a:4,5-a']diindole-6,13(1H,7H)-dione
C18H24N2O2S2
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=6.4416(6)Å b=10.8045(5)Å c=24.627(2)Å
α=90.00° β=90.00° γ=90.00°
(rac)-10a,10'a-bis(methylthio)octahydro-1H,1'H-5a,5'a-bidipyrrolo- [1,2-a:1',2'-d]pyrazine-5,5',10,10'(6H,6'H,10aH,10'aH)-tetraone
C22H30N4O4S2,0.125(H2O)
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=9.648(1)Å b=14.822(2)Å c=16.441(3)Å
α=104.68(1)° β=103.17(1)° γ=91.75(1)°
5a,10a-bis(methylthio)octahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione
C12H18N2O2S2
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=17.1844(13)Å b=7.3729(5)Å c=10.8107(8)Å
α=90.00° β=105.732(3)° γ=90.00°
2,7-bis(benzyloxy)tetrahydro-5a,10a-epidithiodipyrrolo[1,2-a:1',2'-d]- pyrazine-5,10(1H,6H)-dione and 2,7-bis(benzyloxy)tetrahydro-5a,10a-epitrithiodipyrrolo[1,2-a:1',2'-d]- pyrazine-5,10(1H,6H)-dione in the ration 2.69:0.31
2.69(C24H24N2O4S2),0.31(C24H24N2O4S2),2(CHCl3)
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=11.4283(1)Å b=17.1077(2)Å c=19.3984(2)Å
α=90.00° β=92.773(1)° γ=90.00°
C5H10N2P,I
C5H10N2P,I
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=8.4133(14)Å b=7.1479(11)Å c=7.5050(11)Å
α=90° β=90° γ=90°
C28H40N2P,I,2(C2H3N)
C28H40N2P,I,2(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=21.5771(13)Å b=14.8112(8)Å c=21.4093(11)Å
α=90° β=90° γ=90°
C21H26N2P,I,0.5(C2H3N)
C21H26N2P,I,0.5(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=17.8150(8)Å b=19.1134(9)Å c=14.7481(7)Å
α=90° β=114.254(2)° γ=90°
C29H41N2P
C29H41N2P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=40.4446(12)Å b=10.7492(3)Å c=12.5916(3)Å
α=90° β=90° γ=90°
C29H42N2P,BF4
C29H42N2P,BF4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=9.4999(3)Å b=19.6312(7)Å c=16.2528(6)Å
α=90° β=100.794(2)° γ=90°
C30H44N2P,BF4
C30H44N2P,BF4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=9.6514(5)Å b=19.5693(9)Å c=16.5413(7)Å
α=90° β=101.591(2)° γ=90°
C27H38N2P,BF4,CH2Cl2
C27H38N2P,BF4,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=16.2797(11)Å b=19.2139(11)Å c=20.2982(14)Å
α=90° β=90° γ=90°
C29H42N2P,BF4
C29H42N2P,BF4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=18.5540(5)Å b=19.0734(6)Å c=8.1713(2)Å
α=90° β=90° γ=90°
C22H28N2P,BF4
C22H28N2P,BF4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=10.6034(5)Å b=27.3731(13)Å c=16.1467(7)Å
α=90° β=91.181(2)° γ=90°
C27H38N2P,I,0.5(C2H3N),0.5(H2O)
C27H38N2P,I,0.5(C2H3N),0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=30.490(2)Å b=32.625(2)Å c=12.8127(8)Å
α=90° β=90° γ=90°
C54H40Cl6Cu2I2NP3
C54H40Cl6Cu2I2NP3
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=12.3082(4)Å b=24.7061(10)Å c=18.5816(8)Å
α=90° β=104.719(1)° γ=90°
C53H38Cl6Cu2I2NP3
C53H38Cl6Cu2I2NP3
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=10.61070(10)Å b=13.40820(10)Å c=18.7629(2)Å
α=90° β=93.5340(10)° γ=90°
C60H39Cu2F18I2NP3,0.5(CH2Cl2)
C60H39Cu2F18I2NP3,0.5(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=15.2045(10)Å b=15.6811(6)Å c=15.7442(10)Å
α=90.236(4)° β=106.170(5)° γ=116.415(4)°
C21H22NP
C21H22NP
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=10.9170(6)Å b=14.2236(10)Å c=11.8139(6)Å
α=90° β=103.375(4)° γ=90°
C54H40Cu2F6I2NP3,C5H12
C54H40Cu2F6I2NP3,C5H12
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=18.9997(6)Å b=12.9197(5)Å c=23.7991(6)Å
α=90° β=102.080(2)° γ=90°
C53H38Cu2F6I2NP3
C53H38Cu2F6I2NP3
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=18.9070(5)Å b=12.6700(2)Å c=20.7952(5)Å
α=90° β=103.210(2)° γ=90°
C57H46Cu2F6I2NP3
C57H46Cu2F6I2NP3
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=12.6116(7)Å b=17.2115(8)Å c=27.1045(9)Å
α=103.391(3)° β=100.214(4)° γ=101.155(4)°
C59H54Cu2I2NP3,2(CH2Cl2)
C59H54Cu2I2NP3,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=11.2312(2)Å b=14.2065(3)Å c=21.3424(4)Å
α=72.1220(10)° β=82.3480(10)° γ=67.3660(10)°
C59H48Cu2F6I2NP3,CH2Cl2
C59H48Cu2F6I2NP3,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 41 15687-15698
a=19.1297(5)Å b=12.6256(2)Å c=25.3784(6)Å
α=90° β=111.373(2)° γ=90°
C39H32AuClNP,0.5(C6H12)
C39H32AuClNP,0.5(C6H12)
Dalton Transactions (2019)
a=9.9785(4)Å b=13.0028(5)Å c=15.0193(5)Å
α=114.068(1)° β=104.088(1)° γ=97.102(1)°
C5H9IN2P,I
C5H9IN2P,I
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=13.4578(10)Å b=8.6203(7)Å c=9.8671(7)Å
α=90° β=116.365(3)° γ=90°
C9H17IN2P,I
C9H17IN2P,I
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=7.7774(5)Å b=8.4078(6)Å c=11.6208(8)Å
α=84.753(4)° β=79.435(3)° γ=78.409(3)°
C27H37I1N2P,I3
C27H37I1N2P,I3
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=12.5136(7)Å b=16.6700(10)Å c=16.8720(9)Å
α=90° β=108.146(3)° γ=90°
C21H25I2N2P
C21H25I2N2P
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=9.2530(6)Å b=15.3097(11)Å c=16.0029(13)Å
α=90° β=90° γ=90°
C27H37IN2P,I,CH2Cl2
C27H37IN2P,I,CH2Cl2
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=10.7558(6)Å b=18.7258(11)Å c=16.3345(9)Å
α=90° β=102.309(3)° γ=90°
C90H56Eu2F6N4O12,C7H8
C90H56Eu2F6N4O12,C7H8
Chemical communications (Cambridge, England) (2018) 54, 41 5221-5224
a=11.765(7)Å b=22.391(12)Å c=16.151(9)Å
α=90.00° β=110.732(13)° γ=90.00°
C66H34Eu2F12N4O12
C66H34Eu2F12N4O12
Chemical communications (Cambridge, England) (2018) 54, 41 5221-5224
a=14.583(2)Å b=13.1391(17)Å c=15.364(2)Å
α=90° β=103.713(4)° γ=90°
Joerg143 H.Helten ''HHE-298F1'' 100K 13.02.08
C20H28N3O5PSSi2W
New Journal of Chemistry (2010) 34, 8 1593
a=11.8239(2)Å b=20.2887(5)Å c=11.9270(3)Å
α=90.00° β=104.5180(10)° γ=90.00°
(Bis-(mu-2-4-(Diphenylphosphino)methyl-1,2-catecholato)-bis- (mu-2-3-(diphenylphosphino)methyl-hydro-1,2-catecholato)- (dimethylforamide)-yttrium(iii)) chloride dimethylformamide solvate
C79H69ClNO8P4Pd2Y,3(C3H7NO)
New Journal of Chemistry (2010) 34, 7 1348
a=19.804(4)Å b=20.246(4)Å c=21.280(4)Å
α=90.00° β=98.08(2)° γ=90.00°
(mu4-hydroxo-octakis-(mu-3-3-(diphenyl)methyl-1,2- catecholato)-tetra-(dimethylformamide)-tetra-yttrium(iii)-tetra- palladium(ii))trichloride dimethylformamide solvate (penta)hydrate
C164H149N4O21P8Pd4Y4,12(C3H7NO),3(Cl),5(H2O)
New Journal of Chemistry (2010) 34, 7 1348
a=16.3740(2)Å b=18.8825(2)Å c=20.6120(3)Å
α=67.152(1)° β=70.115(1)° γ=74.181(1)°
9-(4-(4-phenyl-1H-1,2,3-triazol-1-yl)phnyl)-9H-carbazole
C26H18N4
RSC Adv. (2014) 4, 23 11528
a=9.171(1)Å b=12.808(1)Å c=16.593(2)Å
α=90.00° β=98.81(1)° γ=90.00°
2-(1-(4-(9H-carbazol-9-yl)phenyl)-1H-1,2,3-triazol-4-yl)propan-2-ol
C23H20N4O
RSC Adv. (2014) 4, 23 11528
a=16.967(1)Å b=9.805(1)Å c=22.225(2)Å
α=90.00° β=90.00° γ=90.00°
(6-(benzoyl)-3-(2-methoxyphenyl)-sydnone imine-4-yl)thio)-(triphenylphosphine)-gold(I)
C34H27AuN3O3PS
RSC Advances (2019) 9, 9 4781
a=11.3805(5)Å b=11.7754(5)Å c=13.5775(5)Å
α=90.886(1)° β=114.586(1)° γ=112.289(1)°
Ethyl-N-(1-morpholinyl-1-thioxo-ethan-2-one)-carbamate
C9H14N2O4S
RSC Advances (2019) 9, 9 4781
a=23.9648(12)Å b=6.5378(3)Å c=14.6598(8)Å
α=90° β=92.9020(10)° γ=90°
Bis((6-(benzoyl)-3-(2-methoxyphenyl)-sydnone imine-4-yl)thio)mercury(II)
C32H24HgN6O6S2
RSC Advances (2019) 9, 9 4781
a=8.5954(11)Å b=11.3147(14)Å c=17.4308(19)Å
α=77.613(4)° β=86.366(4)° γ=70.249(4)°
Bis(6-benzoyl-3-(2-methoxyphenyl)-sydnone imine-4-yl)-mercury(II)
C32H24HgN6O6
RSC Advances (2019) 9, 9 4781
a=10.4627(5)Å b=11.4660(6)Å c=13.4682(7)Å
α=79.335(2)° β=68.151(2)° γ=89.637(2)°
(5-(rac-4-[2.2]paracyclophanyl)phenyl)-10,15,20-triphenylporphyrinato)-copper(II)
C60H42CuN4
RSC Advances (2019) 9, 52 30541
a=18.4877(4)Å b=12.1950(3)Å c=18.7238(5)Å
α=90° β=91.773(2)° γ=90°
1,2,3-Tri-tert.butyl-1,3-2,4-diazaphosphaaluminetidine- trimethylamino-donor
C15H37AlN3P
Chemical Communications (1999) 10 879
a=12.8335(4)Å b=16.7315(5)Å c=18.6500(6)Å
α=90.00° β=90.00° γ=90.00°
Pentacarbonyl-(1-triphenylphosphonio-benzo-[c]-phospholide)chromium(0)
C31H20CrO5P2
Chemical Communications (2000) 17 1637
a=10.2695(4)Å b=11.0128(4)Å c=13.7391(4)Å
α=111.151(2)° β=93.476(2)° γ=110.126(2)°
Tricarbonyl-(1-triphenylphosphonio-benzo-[c]-phospholide)chromium(0)
C29H20CrO3P2
Chemical Communications (2000) 17 1637
a=8.5429(4)Å b=13.2026(9)Å c=21.3056(14)Å
α=90.00° β=97.658(4)° γ=90.00°
C16H44Al2N4P2
C16H44Al2N4P2
Chemical Communications (2002) 13 1422
a=11.5332(6)Å b=9.4303(5)Å c=12.2830(8)Å
α=90.00° β=109.501(2)° γ=90.00°
Tricarbonyl[eta6-1,2,3,4,4a,8a-1-tert.butyldimethylsilyloxy-2,3-diethyl-4-methoxynaphthalene]chromium(0)
C24H32CrO5Si
Chemical Communications (2003) 23 2866-2867
a=11.4329(3)Å b=12.4050(3)Å c=18.1159(5)Å
α=90.00° β=106.186(1)° γ=90.00°
(S)-Tricarbonyl[eta6-4a,5,6,7,8,8a-1-tert.butyldimethylsilyloxy-2,3-diethyl-4-methoxynaphthalene]chromium(0)
C24H32CrO5Si
Chemical Communications (2003) 23 2866-2867
a=10.4461(1)Å b=10.4461(1)Å c=39.4227(4)Å
α=90.00° β=90.00° γ=120.00°
(R)-Tricarbonyl[(eta6-4a,5,6,7,8,8a)-1-tert.butyldimethylsilyloxy-2,3-diethyl-4-methoxynaphthalene]chromium(0)
C24H32CrO5Si
Chemical Communications (2003) 23 2866
a=10.4375(1)Å b=10.4375(1)Å c=39.4397(4)Å
α=90.00° β=90.00° γ=120.00°
(R-Ru)-(p-cymene)-[kappa '2-(N,N)-{(1R,2R)-N-tosyl-1,2-diphenyl- ethylenediamine}]ruthenium methylsulfonamidate
C32H39N3O4RuS2
Chemical communications (Cambridge, England) (2011) 47, 17 4911-4913
a=9.0303(2)Å b=13.7496(3)Å c=25.4242(6)Å
α=90.00° β=90.00° γ=90.00°
(S-Ru)-(p-cymene)-[kappa '2-(N,N)-{(1R,2R)-N-tosyl-1,2-diphenyl- ethylenediamine}]ruthenium trifluoromethylsulfonamidate
C32H36F3N3O4RuS2
Chemical communications (Cambridge, England) (2011) 47, 17 4911-4913
a=9.0451(1)Å b=13.9640(1)Å c=25.3405(3)Å
α=90.00° β=90.00° γ=90.00°
C29H28N2O3S
C29H28N2O3S
Chemical communications (Cambridge, England) (2011) 47, 17 4911-4913
a=12.47700(10)Å b=17.6950(2)Å c=12.67200(10)Å
α=90.00° β=112.7570(2)° γ=90.00°
4,5-Dihydroxy-7-oxa-bicyclo[4.1.0]hept-2-ene-3-carboxylic acid methyl ester
C8H10O5
Chemical Communications (2002) 5 494
a=8.6140(2)Å b=4.56550(10)Å c=11.0991(4)Å
α=90.00° β=112.515(2)° γ=90.00°
Benzoic acid 5,6-dihydroxy-3,8-dioxa-tricyclo[5.1.0.0^2,4^]oct-4- ylmethyl ester
C14H14O6
Chemical Communications (2002) 5 494
a=8.8867(2)Å b=11.7119(2)Å c=12.0177(3)Å
α=90.00° β=90.00° γ=90.00°
4-(2-hydroxyl-5-methylphenyl)-1-phenyl-4H-1,2,4-triazol-1-iumperchlorate
C15H14N3O,ClO4
Chem.Commun. (2015) 51, 477
a=6.0904(5)Å b=7.6950(5)Å c=16.3916(13)Å
α=83.899(6)° β=82.995(7)° γ=87.213(6)°
4-methyl-2-(1-phenyl-4H-1,2,4-triazol-1-ium-4-yl)phenolate hydrate
C15H13N3O,H2O
Chem.Commun. (2015) 51, 477
a=19.9626(9)Å b=4.6037(2)Å c=15.3349(6)Å
α=90° β=112.829(5)° γ=90°
(4-methyl-2-(1-phenyl-4H-1,2,4-triazol-1-ium-4-yl)phenoxy)tris(perfluorophenyl)borate
C33H13BF15N3O
Chem.Commun. (2015) 51, 477
a=11.777(1)Å b=12.266(1)Å c=12.551(1)Å
α=76.40(1)° β=64.72(1)° γ=64.59(1)°
4,4-diethyl-3-phenyl-4JH-benzo[e][1,2,4]triazolo[3,4-c]81,4,2]oxaza-borinin-3-ium-4-uide
C18H20BN3O1,0.5(H2O)
Chem.Commun. (2015) 51, 477
a=9.0122(4)Å b=11.1230(5)Å c=17.8748(9)Å
α=72.078(4)° β=87.907(4)° γ=79.532(4)°
(R,Rp)/(S,Sp)-1-([2.2]paracyclophane-4-yl)-N,N-(dimethyl)-ethylamine
C20H25N
Chem.Commun. (2015) 51, 4793
a=10.529(1)Å b=11.655(1)Å c=12.596(1)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Phenylsulfanyl-[2.2]paracyclophane-16-yl)-N,N-(dimethyl)-ethylamine
C26H29NS
Chem.Commun. (2015) 51, 4793
a=7.535(1)Å b=14.973(2)Å c=18.844(2)Å
α=90.00° β=95.77(1)° γ=90.00°
(rac)-5-N,N-dimethylaminomethyl-4-Methylsulfanyl-[2.2]paracyclophane
C20H25NS
Chem.Commun. (2015) 51, 4793
a=8.104(1)Å b=8.358(1)Å c=24.688(3)Å
α=90.00° β=96.20(1)° γ=90.00°
(Rp,R)/(Sp,S)-5-N,N-dimethylaminomethyl-4-Methylsulfanyl-[2.2]paracyclophane
C20H25NS
Chem.Commun. (2015) 51, 4793
a=7.812(1)Å b=11.736(1)Å c=18.668(2)Å
α=90.00° β=96.49(1)° γ=90.00°
4,7-bis(4-methoxycarboxyphenyl)[2.2]paracyclophane
C32H28O4
Chem.Commun. (2015) 51, 4796
a=10.2761(2)Å b=15.2040(3)Å c=15.2549(3)Å
α=90.00° β=96.857(1)° γ=90.00°
3-mesityl-1,2,3-oxadiazol-3-ium-5-olate
C11H12N2O2
Chem.Commun. (2014) 50, 11822
a=7.423(1)Å b=8.934(2)Å c=9.001(2)Å
α=118.77(1)° β=97.71(1)° γ=93.62(1)°
C44H35BrN2O2P2Pd
C44H35BrN2O2P2Pd
Chem.Commun. (2014) 50, 11822
a=11.8099(9)Å b=17.9947(14)Å c=17.1796(7)Å
α=90.00° β=100.544(7)° γ=90.00°
1,3-Di-tert.butyl-2-chloro-1,3,2-diazastibolene
C10H20ClN2Sb
Chemical Communications (2004) 21 2434-2435
a=11.5242(5)Å b=10.9946(4)Å c=21.0980(9)Å
α=90.00° β=90.00° γ=90.00°
1,3-Di-tert.butyl-2-chloro-1,3,2-diazastibolenium tetrachloroantmonate
C10H20Cl4N2Sb2
Chemical Communications (2004) 21 2434-2435
a=10.1078(1)Å b=19.5200(2)Å c=10.2340(1)Å
α=90.00° β=114.408(1)° γ=90.00°
N,N'-Di-tert.butyl-diazadiene antimopny trichloride, antimony trichloride adduct
C10H20Cl3N2SbSbCl3
Chemical Communications (2004) 21 2434-2435
a=12.0617(1)Å b=17.4255(2)Å c=19.3913(2)Å
α=90.00° β=102.081(1)° γ=90.00°
1,3-Di-tert.butyl-2-chloro-1,3,2-diazastibolenium trisfluoromethane sulfonate
C10H20N2SbCF3SO3CH2Cl2
Chemical Communications (2004) 21 2434-2435
a=11.0192(1)Å b=10.3184(1)Å c=18.6936(2)Å
α=90.00° β=104.138(1)° γ=90.00°
N,N'-ethylene-bis(4-octyloxysalicylideneiminato)copper(ii)
C32H46CuN2O4
CrystEngComm (2011) 13, 14 4701
a=43.444(8)Å b=7.254(2)Å c=9.702(2)Å
α=90.00° β=92.54(2)° γ=90.00°
N,N'-(o-phenylene)bis(4- hexyloxysalicylideneiminato)copper(ii) dichloromethane solvate
C32H38CuN2O4,C1H2Cl2
CrystEngComm (2011) 13, 14 4701
a=19.521(2)Å b=14.028(2)Å c=12.066(3)Å
α=90.00° β=99.20(2)° γ=90.00°
N,N'-(o-phenylene)bis(4-decyloxysalicylideneiminato)nickel(ii)
C40H54N2NiO4
CrystEngComm (2011) 13, 14 4701
a=14.940(6)Å b=5.532(2)Å c=42.014(2)Å
α=90.00° β=90.754(7)° γ=90.00°